[THE INVESTOR] On Oct. 18, LG Life Sciences (068870) increased 2.31% to 62,100 won (US$ 54.81). It had declined 6.36% through the past month. Standard deviation, the risk index for stock price, was 2.2% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSPI, since the monthly volatility of LG Life Sciences was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.8%. As bearish stock price trend, the return-on-risk was poor, compared with its peer group. Moreover, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 2.4, and thus it is hard to say that the industrial comparison performance was positive.

While institutions have been buying LG Life Sciences during the past 2 trading days, foreigners have been selling during the past 2 trading days. As a shareholding sum by investor group for the past 4 weeks, institutions have bought 20,846 shares as they turn toward a buying stance and individuals have bought 52,351 shares lessening its position. However, during the same period, foreigners have sold 73,197 shares.

Cumulated shareholdings per investor group (1Mo) Total shareholdings per investor group

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.